Sildenafil Tablet, Film Coated
Product Images NDC 43353-345

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 43353-345). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

Principal Display Panel (20 mg Tablet Bottle Label)
The text describes a medication called Sildenafil, which comes in the form of 10 tablets that contain 20mg of the active ingredient.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure 1 (Sildenafil 01)

FDA Label Image

Chemical Structure (Sildenafil 02)

FDA Label Image

Figure 2 (Sildenafil 03)

Figure 2 (Sildenafil 03)
This text appears to be a medication interaction chart, with different drugs listed with recommendations on adjusting dosages based on their effect on the drug's AUC and cmax. The drugs listed include atorvastatin, azithromycin, bosentan, cimetidine, erythromycin, Maalox, oral contraceptives, ritonavir, and saquinavir. There also appears to be a graph showing changes in drug effectiveness relative to sildenafil alone.*
FDA Label Image

Figure 3 (Sildenafil 04)

Figure 3 (Sildenafil 04)
This is a list of drugs that interact with Acenocoumarol. The table shows the effects of co-administering certain drugs with Acenocoumarol, including Aspirin, Atorvastatin, Bosentan, Doxazosin, Ethinyloestradiol, Levonorgestrel, Phenprocoumon, Ritonavir, and Tolbutamide. Recommended dose adjustments are listed for each drug combination as well as the effect on INR AUC, INR Cmax, and BT. The table also shows the fold change and 90% CI of each interaction. However, there is some text missing or unreadable, marked by asterisks, which may impact the overall interpretation and usefulness of this information.*
FDA Label Image

Figure 4 (Sildenafil 05)

Figure 4 (Sildenafil 05)
This document appears to be a chart displaying the change in meters from a baseline measurement. The chart also includes various labels, such as "Week 4" and "Week 12," as well as different dosages of sildenafil (a medication commonly used for erectile dysfunction), ranging from 0 mg (the placebo) to 80 mg taken three times a day (labelled "+—— Sildenatt 40mg TID" and "4= Sildenaft 80mg TID" respectively).*
FDA Label Image

Figure 5 (Sildenafil 06)

Figure 5 (Sildenafil 06)
This text seems to contain medical information related to the dosing of Sidenafil, a drug that is typically used to treat erectile dysfunction and pulmonary arterial hypertension. The text also includes some numerical data about the medication's effectiveness in improving functional capacity and therapeutic class. The last section appears to show the placebo-corrected change in a six-minute walk distance, but it is incomplete and thus not entirely clear.*
FDA Label Image

Figure 6 (Sildenafil 07)

FDA Label Image

Figure 7 (Sildenafil 08)

FDA Label Image

Greenstone Logo (Sildenafil 09)

Greenstone Logo (Sildenafil 09)
This is a description of the Greenstone brand, which is distributed by Greenstone LLC and located in Peapack, NJ 07977.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.